Allergies News and Research

Latest Allergies News and Research

UT Southwestern awarded $763,000 as grant to expand studies of Peregrine's anti-PS antibodies

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that the U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded a two-year, $763,000 grant to Philip Thorpe, Ph.D., of the University of Texas Southwestern Medical Center for research expanding its studies of anti-phosphatidylserine (anti-PS) antibodies as potential treatments for viral hemorrhagic fever (VHF) infections.

26 Aug 2009

HealthCore study reports that oral controllers provide better clinical outcomes for asthma patients

Mayo Clinic Proceedings published a peer-reviewed comparative effectiveness study performed by HealthCore, Inc. in its August edition. The study demonstrated that in general had better clinical outcomes with oral controllers than inhaled corticosteroids.

26 Aug 2009

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.

26 Aug 2009

Genvec to use $2.5 million grant from NIAID for the development of novel cell lines

GenVec, Inc. (Nasdaq: GNVC) announced today that it has received a Phase 2 Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the development of GenVec's vector production technology.

25 Aug 2009

Damprid offers moisture absorbers that control moisture and eliminate dampness in homes

Frequent, heavy rain showers can bring needed relief from warm temperatures during the summer, however, the resulting increase in moisture and humidity makes it important to maintain a dry, healthy environment inside the home. Moisture that seeps into the home through cracks and crevices can lead to musty odors, allergens, mold and mildew that lead to or aggravate allergies, asthma and other health concerns and can even lead to structural damage.

25 Aug 2009

NIAID to establish a human immune profiling research consortium in 2010; invites grant applications

The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, is accepting grant applications for a new initiative to establish a consortium of human immune profiling research centers.

25 Aug 2009

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

UCB and sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved XYZAL(R) (levocetirizine dihydrochloride) for children age six months and older for the relief of symptoms of perennial allergic rhinitis (indoor allergies) and chronic idiopathic urticaria (chronic hives) and for children age two years and older for symptoms of seasonal allergic rhinitis (outdoor allergies).

25 Aug 2009

NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drug

Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).

25 Aug 2009

Report assessing school-based policies that address the health of students released by AAFA

For over 8 million children with asthma, food allergies and related conditions, the school-house is a focal point for managing their diseases. Now for the second year in a row, the Asthma and Allergy Foundation of America (AAFA) has released a report assessing school-based policies that address student health for elementary, middle and high schools in all 50 states.

25 Aug 2009

Advisory labels to help combat swine flu

Out With Allergies LLC has announced the introduction of FluNotes(TM), "Wash Hands Fight Flu"(TM) advisory labels as a potent new weapon for combating swine flu. Available through their website, www.FluNotes.com, these stick-on notes are intended to make people more aware that they must wash their hands frequently to avoid catching and spreading the flu.

24 Aug 2009

Consumer-friendly "finger stick" blood test to detect cardiovascular disease is broadly available now

A new blood test, measuring the level of omega-3 fatty acids in red blood cells, is now broadly available for the first time to the public everywhere as a consumer-friendly, at-home "finger stick" test. While scientists have long known of the benefits of fish and fish oil for overall heart health, over the past decade research has proven that the omega-3 fatty acids found in fish dramatically reduce one's risk for cardiovascular disease. Further, recent research indicates that omega-3 levels may be among the best predictors of future coronary heart disease - providing much stronger correlations to the risk of sudden cardiac death than traditional indicators, including HDL and LDL cholesterol.

20 Aug 2009

UT Southwestern Medical Center: Human gut bacteria ward off Toxoplasma gondii

Immunology researchers at UT Southwestern Medical Center have found that bacteria present in the human gut help initiate the body's defense mechanisms against Toxoplasma gondii, the parasite responsible for toxoplasmosis.

20 Aug 2009

Inovio Biomedical records $2.9 million revenues in the six months ended June 30, 2009

Inovio Biomedical Corporation (NYSE AMEX: INO) (“Inovio”) today reported financial results for the three and six months ended June 30, 2009. Total revenue of $2.5 million and $2.9 million for the three and six months ended June 30, 2009, compared to $663,000 and $1.3 million for the three and six months ended June 30, 2008, respectively.

20 Aug 2009

U.S.District Court ruling favors Merck in patent infringement suit against Teva Pharmaceuticals

Merck & Co., Inc. announced today that the U.S. District Court for the District of New Jersey has ruled in Merck's favor in a patent infringement suit against Teva Pharmaceuticals USA Inc. (Teva).

20 Aug 2009

FDA approves Hiberix Haemophilus influenzae type b vaccine

In response to a U.S. shortage of a vaccine to protect infants from Haemophilus influenzae type b (Hib), GlaxoSmithKline (NYSE: GSK) has received accelerated approval from the FDA (Food and Drug Administration) for Hiberix((R)) [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] as a booster dose in children 15 months through four years of age. Hib is an often severe and potentially deadly bacterial infection that can cause meningitis.

19 Aug 2009

U.S. Food and Drug Administration launches new Center for Tobacco Products

The U.S. Food and Drug Administration today launched its new Center for Tobacco Products in an historic effort to curb the hundreds of thousands of deaths caused by those products each year.

19 Aug 2009

H1N1 vaccine orders top 1 billion, WHO Says

"Northern hemisphere countries have so far ordered more than one billion doses of swine flu vaccine, the World Health Organisation said Tuesday, sparking warnings over shortages," Agence France-Presse reports. While some countries, including Greece, The Netherlands, Canada and Israel, have ordered enough vaccine to inoculate their citizens, "[o]thers, such as Germany, the United States, Britain and France, have put in orders that would cover between 30 and 78 percent of people," the news service writes.

19 Aug 2009

Amira Pharmaceuticals submits IND for inflammatory and allergic disease treatment candidate

Amira Pharmaceuticals, Inc. announced today the submission of an Investigational New Drug application (IND) of AM461, its internally-discovered, oral drug candidate for the treatment and control of inflammatory and allergic disease linked to the arachidonic acid pathway, to the U.S. Food and Drug Administration.

19 Aug 2009

Two American Oriental Bioengineering products bag China's Top Branded Drugs of 2009 award

American Oriental Bioengineering, Inc. today announced that two of AOBO's branded products, Jinji Capsules and Boke Nasal Spray, were awarded the designation of "China's Top Branded Drugs of 2009" at an award ceremony held in Shanghai on August 11, 2009.

19 Aug 2009

FDA approves Extavia for multiple sclerosis

The US Food and Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease.

17 Aug 2009

Allergies News and Research

Latest Allergies News and Research

UT Southwestern awarded $763,000 as grant to expand studies of Peregrine's anti-PS antibodies

HealthCore study reports that oral controllers provide better clinical outcomes for asthma patients

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Genvec to use $2.5 million grant from NIAID for the development of novel cell lines

Damprid offers moisture absorbers that control moisture and eliminate dampness in homes

NIAID to establish a human immune profiling research consortium in 2010; invites grant applications

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drug

Report assessing school-based policies that address the health of students released by AAFA

Advisory labels to help combat swine flu

Consumer-friendly "finger stick" blood test to detect cardiovascular disease is broadly available now

UT Southwestern Medical Center: Human gut bacteria ward off Toxoplasma gondii

Inovio Biomedical records $2.9 million revenues in the six months ended June 30, 2009

U.S.District Court ruling favors Merck in patent infringement suit against Teva Pharmaceuticals

FDA approves Hiberix Haemophilus influenzae type b vaccine

U.S. Food and Drug Administration launches new Center for Tobacco Products

H1N1 vaccine orders top 1 billion, WHO Says

Amira Pharmaceuticals submits IND for inflammatory and allergic disease treatment candidate

Two American Oriental Bioengineering products bag China's Top Branded Drugs of 2009 award

FDA approves Extavia for multiple sclerosis

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Allergies News and Research

Latest Allergies News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in